Open AccessCerebral microbleeds: A new dilemma in stroke medicine
Author(s) -
Puneet Kakar,
Andreas Charidimou,
David J. Werring
Publication year - 2012
Publication title -
jrsm cardiovascular disease
Language(s) - English
Resource type - Journals
ISSN - 2048-0040
DOI - 10.1177/2048004012474754
Subject(s) - medicine , stroke (engine) , antithrombotic , context (archaeology) , intensive care medicine , dementia , neuroimaging , intracerebral hemorrhage , cerebral amyloid angiopathy , dilemma , anticoagulant , disease , psychiatry , subarachnoid hemorrhage , engineering , mechanical engineering , philosophy , epistemology , paleontology , biology
Cerebral microbleeds (CMBs) are an increasingly common neuroimaging finding in the context of ageing, cerebrovascular disease and dementia, with potentially important clinical relevance. Perhaps the most pressing clinical question is whether CMBs are associated with a clinically important increase in the risk of intracerebral haemorrhage (ICH), the most feared complication in patients treated with thrombolytic or antithrombotic (antiplatelet and anticoagulant) drugs. This review will summarize the evidence available regarding CMBs as an indicator of future ICH risk in stroke medicine clinical practice
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom